BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 27495938)

  • 21. Preventive Triple Gene Therapy Reduces the Negative Consequences of Ischemia-Induced Brain Injury after Modelling Stroke in a Rat.
    Markosyan V; Safiullov Z; Izmailov A; Fadeev F; Sokolov M; Kuznetsov M; Trofimov D; Kim E; Kundakchyan G; Gibadullin A; Salafutdinov I; Nurullin L; Bashirov F; Islamov R
    Int J Mol Sci; 2020 Sep; 21(18):. PubMed ID: 32962079
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Triple-Gene Therapy for Stroke: A Proof-of-Concept
    Sokolov ME; Bashirov FV; Markosyan VA; Povysheva TV; Fadeev FO; Izmailov AA; Kuztetsov MS; Safiullov ZZ; Shmarov MM; Naroditskyi BS; Palotás A; Islamov RR
    Front Pharmacol; 2018; 9():111. PubMed ID: 29497380
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Increased survival and function of SOD1 mice after glial cell-derived neurotrophic factor gene therapy.
    Acsadi G; Anguelov RA; Yang H; Toth G; Thomas R; Jani A; Wang Y; Ianakova E; Mohammad S; Lewis RA; Shy ME
    Hum Gene Ther; 2002 Jun; 13(9):1047-59. PubMed ID: 12067438
    [TBL] [Abstract][Full Text] [Related]  

  • 24. VEGF delivery with retrogradely transported lentivector prolongs survival in a mouse ALS model.
    Azzouz M; Ralph GS; Storkebaum E; Walmsley LE; Mitrophanous KA; Kingsman SM; Carmeliet P; Mazarakis ND
    Nature; 2004 May; 429(6990):413-7. PubMed ID: 15164063
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Muscle-derived but not centrally derived transgene GDNF is neuroprotective in G93A-SOD1 mouse model of ALS.
    Li W; Brakefield D; Pan Y; Hunter D; Myckatyn TM; Parsadanian A
    Exp Neurol; 2007 Feb; 203(2):457-71. PubMed ID: 17034790
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Human umbilical cord blood cells transfected with VEGF and L(1)CAM do not differentiate into neurons but transform into vascular endothelial cells and secrete neuro-trophic factors to support neuro-genesis-a novel approach in stem cell therapy.
    Rizvanov AA; Kiyasov AP; Gaziziov IM; Yilmaz TS; Kaligin MS; Andreeva DI; Shafigullina AK; Guseva DS; Kiselev SL; Matin K; Palotás A; Islamov RR
    Neurochem Int; 2008 Dec; 53(6-8):389-94. PubMed ID: 18948156
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Ex Vivo Gene Therapy Using Human Mesenchymal Stem Cells to Deliver Growth Factors in the Skeletal Muscle of a Familial ALS Rat Model.
    Suzuki M; Svendsen CN
    Methods Mol Biol; 2016; 1382():325-36. PubMed ID: 26611598
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Retrograde viral delivery of IGF-1 prolongs survival in a mouse ALS model.
    Kaspar BK; Lladó J; Sherkat N; Rothstein JD; Gage FH
    Science; 2003 Aug; 301(5634):839-42. PubMed ID: 12907804
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Adenovirus-mediated gene transfer of glial cell line-derived neurotrophic factor prevents motor neuron loss of transgenic model mice for amyotrophic lateral sclerosis.
    Manabe Y; Nagano I; Gazi MS; Murakami T; Shiote M; Shoji M; Kitagawa H; Setoguchi Y; Abe K
    Apoptosis; 2002 Aug; 7(4):329-34. PubMed ID: 12101392
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Disruption of the astrocytic TNFR1-GDNF axis accelerates motor neuron degeneration and disease progression in amyotrophic lateral sclerosis.
    Brambilla L; Guidotti G; Martorana F; Iyer AM; Aronica E; Valori CF; Rossi D
    Hum Mol Genet; 2016 Jul; 25(14):3080-3095. PubMed ID: 27288458
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Intrathecal injection of epidermal growth factor and fibroblast growth factor 2 promotes proliferation of neural precursor cells in the spinal cords of mice with mutant human SOD1 gene.
    Ohta Y; Nagai M; Nagata T; Murakami T; Nagano I; Narai H; Kurata T; Shiote M; Shoji M; Abe K
    J Neurosci Res; 2006 Oct; 84(5):980-92. PubMed ID: 16902995
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Intrathecal application of neuroectodermally converted stem cells into a mouse model of ALS: limited intraparenchymal migration and survival narrows therapeutic effects.
    Habisch HJ; Janowski M; Binder D; Kuzma-Kozakiewicz M; Widmann A; Habich A; Schwalenstöcker B; Hermann A; Brenner R; Lukomska B; Domanska-Janik K; Ludolph AC; Storch A
    J Neural Transm (Vienna); 2007; 114(11):1395-406. PubMed ID: 17510731
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Activation of mGlu3 metabotropic glutamate receptors enhances GDNF and GLT-1 formation in the spinal cord and rescues motor neurons in the SOD-1 mouse model of amyotrophic lateral sclerosis.
    Battaglia G; Riozzi B; Bucci D; Di Menna L; Molinaro G; Pallottino S; Nicoletti F; Bruno V
    Neurobiol Dis; 2015 Feb; 74():126-36. PubMed ID: 25434487
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Intravenous administration of human umbilical cord blood cells in a mouse model of amyotrophic lateral sclerosis: distribution, migration, and differentiation.
    Garbuzova-Davis S; Willing AE; Zigova T; Saporta S; Justen EB; Lane JC; Hudson JE; Chen N; Davis CD; Sanberg PR
    J Hematother Stem Cell Res; 2003 Jun; 12(3):255-70. PubMed ID: 12857367
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Intrathecal transplantation of human neural stem cells overexpressing VEGF provide behavioral improvement, disease onset delay and survival extension in transgenic ALS mice.
    Hwang DH; Lee HJ; Park IH; Seok JI; Kim BG; Joo IS; Kim SU
    Gene Ther; 2009 Oct; 16(10):1234-44. PubMed ID: 19626053
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Intracerebroventricular administration of human umbilical cord blood cells delays disease progression in two murine models of motor neuron degeneration.
    Bigini P; Veglianese P; Andriolo G; Cova L; Grignaschi G; Caron I; Daleno C; Barbera S; Ottolina A; Calzarossa C; Lazzari L; Mennini T; Bendotti C; Silani V
    Rejuvenation Res; 2011 Dec; 14(6):623-39. PubMed ID: 21978082
    [TBL] [Abstract][Full Text] [Related]  

  • 37. In vitro non-viral lipofectamine delivery of the gene for glial cell line-derived neurotrophic factor to human umbilical cord blood CD34+ cells.
    Yu G; Borlongan CV; Ou Y; Stahl CE; Yu S; Bae E; Kaneko Y; Yang T; Yuan C; Fang L
    Brain Res; 2010 Apr; 1325():147-54. PubMed ID: 20171195
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Improved lentiviral transduction of ALS motoneurons in vivo via dual targeting.
    O'Leary VB; Ovsepian SV; Bodeker M; Dolly JO
    Mol Pharm; 2013 Nov; 10(11):4195-206. PubMed ID: 24066863
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Gene transfer for neuroprotection in animal models of Parkinson's disease and amyotrophic lateral sclerosis.
    Bohn MC; Connor B; Kozlowski DA; Mohajeri MH
    Novartis Found Symp; 2000; 231():70-89; discussion 89-93. PubMed ID: 11131547
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A genetic fusion GDNF-C fragment of tetanus toxin prolongs survival in a symptomatic mouse ALS model.
    Ciriza J; Moreno-Igoa M; Calvo AC; Yague G; Palacio J; Miana-Mena FJ; Muñoz MJ; Zaragoza P; Brûlet P; Osta R
    Restor Neurol Neurosci; 2008; 26(6):459-65. PubMed ID: 19096133
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.